NDC 0220-0871

Blatta orientalis

Blatta Orientalis

Blatta orientalis is a Oral Pellet in the Human Otc Drug category. It is labeled and distributed by Laboratoires Boiron. The primary component is Blatta Orientalis.

Product ID0220-0871_5f4b8475-a794-3832-e053-2991aa0a406e
NDC0220-0871
Product TypeHuman Otc Drug
Proprietary NameBlatta orientalis
Generic NameBlatta Orientalis
Dosage FormPellet
Route of AdministrationORAL
Marketing Start Date1983-03-03
Marketing CategoryUNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
Labeler NameLaboratoires Boiron
Substance NameBLATTA ORIENTALIS
Active Ingredient Strength5 [hp_C]/1
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 0220-0871-41

80 PELLET in 1 TUBE (0220-0871-41)
Marketing Start Date1983-03-03
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0220-0871-41 [00220087141]

Blatta orientalis PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date1983-03-03

Drug Details

Active Ingredients

IngredientStrength
BLATTA ORIENTALIS5 [hp_C]/1

OpenFDA Data

SPL SET ID:2ed68490-7c4f-11e6-8334-424c58303031
Manufacturer
UNII

NDC Crossover Matching brand name "Blatta orientalis" or generic name "Blatta Orientalis"

NDCBrand NameGeneric Name
0220-0868Blatta orientalisBLATTA ORIENTALIS
0220-0869Blatta orientalisBLATTA ORIENTALIS
0220-0871Blatta orientalisBLATTA ORIENTALIS
0220-0872Blatta orientalisBLATTA ORIENTALIS
0220-0873Blatta orientalisBLATTA ORIENTALIS
15631-0083BLATTA ORIENTALISBLATTA ORIENTALIS
15631-0540BLATTA ORIENTALISBLATTA ORIENTALIS
63545-499Blatta OrientalisBlatta Orientalis
63545-500Blatta OrientalisBlatta Orientalis
63545-501Blatta OrientalisBlatta Orientalis
63545-502Blatta OrientalisBlatta Orientalis
63545-503Blatta OrientalisBlatta Orientalis
63545-504Blatta OrientalisBlatta Orientalis
63545-505Blatta OrientalisBlatta Orientalis
68428-259Blatta orientalisBLATTA ORIENTALIS
71919-125Blatta orientalisBLATTA ORIENTALIS
69152-1020Blatta orientalis 30CBlatta orientalis
64117-117CoughBLATTA ORIENTALIS

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.